Trial finds low dose ramipril does not reduce cardiovascular or renal events in people with type 2 diabetes and albuminuria: Abstracted from: Marre M, Lievre M, Chatellier G, et al. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ 2004; 328(7438): 495–500.

• Book ID: 116415743
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 125 KB
• Volume: 8
• Category: Article
• ISSN: 1361-2611
• DOI: 10.1016/j.ebcm.2004.06.026